According to the CiPA initiative, Safe Cardiac Action Potential Test (SCAP Test) offers in silico computational modeling and simulation of cardiac action potential which can help you to identify some drug cardiac liabilities (such as early after depolarisation (EAD), transmural dispersion of repolarisation (TDR), triangulation, reverse use dependence, action potential duration (APD) prolongation or shortening, Vmax increase or decrease,….)